Skip to main content
. Author manuscript; available in PMC: 2014 Aug 28.
Published in final edited form as: Cancer Lett. 2013 May 17;337(1):77–89. doi: 10.1016/j.canlet.2013.05.017

Fig. 5.

Fig. 5

Lapatinib-resistant IBC cells are cross-resistant to multiple oncology drugs. (A) Heat map proliferation profile of five most potent drugs identified for SUM149 and corresponding profile on rSUM149 and rrSUM149 cells. (B) Comparative heat map proliferation profile of tyrosine kinase drugs on parental SUM149 and isogenic rSUM149 and rrSUM149 cells. (C) Comparative IC50 values for drugs demonstrating cross-resistance and cross-resensitization. Mean (bars) and SD (error bars) with IC50 values determined using GraphPad Prism 5.0.